Related Experiment Videos
Syncopal episodes in a young amateur body builder
G Manoharan1, N P S Campbell, C J O'Brien
1Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, Northern Ireland, UK. gmanoharan@msn.com
British Journal of Sports Medicine
|February 28, 2002
Summary
A weightlifter experienced fainting spells due to atrial fibrillation, likely caused by bromocriptine misuse. This case highlights potential cardiac risks associated with certain performance-enhancing drug combinations.
Area of Science:
- Cardiology
- Pharmacology
- Sports Medicine
Background:
- Weight training enthusiasts may use performance-enhancing substances.
- Anabolic steroids and bromocriptine are sometimes misused in fitness communities.
- Cardiac arrhythmias are a potential adverse effect of drug misuse.
Observation:
- A 36-year-old male weight training participant presented with recurrent syncopal episodes.
- Electrocardiogram revealed atrial fibrillation with a normal ventricular rate.
- The patient reported concurrent use of anabolic steroids and bromocriptine.
Findings:
- Atrial fibrillation in this case was strongly suspected to be a consequence of bromocriptine misuse.
- The combination of anabolic steroids and bromocriptine may pose cardiac risks.
- This case underscores the importance of detailed substance use history in patients with arrhythmias.
Implications:
- Clinicians should consider drug-induced arrhythmias in athletes presenting with syncope or atrial fibrillation.
- Screening for anabolic steroid and bromocriptine use is crucial in relevant patient populations.
- Further research is warranted on the cardiovascular effects of combined substance use in athletes.